Related Experiment Video
Updated: Nov 23, 2025

Automated, Quantitative Cognitive/Behavioral Screening of Mice: For Genetics, Pharmacology, Animal Cognition and Undergraduate Instruction
Published on: February 26, 2014
Time in Range: How to Measure It, How to Report It, and Its Practical Application in Clinical Decision-Making
Eugene E Wright1, Kayla Morgan2, Danny K Fu2
1Charlotte Area Health Education Center, Charlotte, NC.
Glycemic time in range offers a more holistic view of blood sugar control than the traditional A1C test. This new standard, using continuous glucose monitoring, provides a clearer picture of patient glycemic status.
Area of Science:
- Endocrinology
- Metabolic Health
- Diabetes Management
Background:
- Hemoglobin A1C (HbA1c) has long been the standard for assessing long-term glycemic control.
- HbA1c provides an average glucose level, masking glycemic variability and individual fluctuations.
- Limitations of HbA1c include its susceptibility to factors affecting red blood cell turnover and its inability to reflect rapid glucose changes.
Purpose of the Study:
- To review glycemic time in range (TIR) as a superior metric for assessing glycemia.
- To highlight the advantages of TIR over traditional A1C measurements.
- To summarize findings and recommendations from the International Consensus Group on Time in Range.
Main Methods:
- Review of current literature and established guidelines on glycemic monitoring.
- Analysis of data from continuous glucose monitoring (CGM) systems.
- Synthesis of information presented by the International Consensus Group on Time in Range.
Main Results:
- Glycemic time in range (TIR) offers a more comprehensive assessment of glucose control compared to A1C.
- TIR quantifies the percentage of time glucose levels remain within a target range, reflecting glycemic stability.
- CGM data enables the calculation of TIR, providing insights into glucose variability, highs, and lows.
Conclusions:
- Glycemic time in range is emerging as the new gold standard for assessing glycemic control in patients using CGM.
- TIR provides a more dynamic and patient-centered view of diabetes management than A1C.
- Adoption of TIR facilitates more personalized and effective diabetes care strategies.
Related Concept Videos
Measurement of Bioavailability: Pharmacodynamic Methods
Therapeutic Drug Monitoring: Overview and Classification
Therapeutic Drug Monitoring: Affecting Factors
Guidelines For Measuring Vital Signs
Before taking a patient's vital signs, a nurse would consider and assess the patient's comfort level and ensure appropriate equipment is available.
Introduction To Survival Analysis
The primary goal of survival analysis is to estimate survival time—the time...
Temperature Measurement Sites
Oral: When assessing oral temperature, the thermometer tip should be placed under the tongue in the posterior sublingual pocket. It offers accurate readings and can be...

